The Curosurf story is a tale of success. To date, the drug has saved the lives
of around one million premature babies worldwide. And the story is far from
over. Despite being 73, Tore Curstedt returns to the lab every day – the lab
where he has developed a new variant of a drug that is set to help many more
babies in the future.
If you want to read more about Tore Curstedt and Curosurf you can find the entire interview in our booklet 20 Years of innovation @ Karolinska Institutet